On February 5, 2026, the Trump administration launched TrumpRx.gov — a federal platform listing discounted cash prices on brand-name prescription medications. Starting with 43 drugs from five manufacturers, the platform has since expanded to over 800 medications. But the discounts work very differently depending on your insurance status, and millions of patients who assume they qualify actually don’t.
These are the questions that matter most — the ones getting lost in the headlines. Answered directly, without the spin from either side.
TrumpRx.gov is a federal government website, launched February 5, 2026, that lists discounted cash prices on select brand-name prescription drugs. It grew out of Executive Order 14297, signed May 12, 2025, which directed the Trump administration to pursue “Most-Favored-Nation” (MFN) pricing — tying U.S. drug prices to the lowest prices paid in comparable developed countries. The first MFN deal was struck with Pfizer on September 30, 2025, followed by AstraZeneca, then 11 others by December 2025. By mid-2026, 26 manufacturers had signed agreements. The platform doesn’t sell drugs directly — it’s a price directory and coupon portal that connects you to manufacturer websites or participating pharmacies.
For the original TrumpRx cash-pay discounts — no. The platform explicitly excludes anyone enrolled in Medicare, Medicaid, TRICARE, VA healthcare, or any other government-funded health program. This is not a bureaucratic quirk; it’s driven by federal anti-kickback laws that restrict how manufacturers can discount drugs for government program beneficiaries. However, Medicare patients gained separate access to MFN-aligned GLP-1 pricing starting mid-2026 — GLP-1 drugs (Ozempic, Wegovy, Zepbound) for qualifying Medicare patients were capped at a $50 monthly copay under Medicaid agreements, administered through your Part D plan, not through TrumpRx.gov directly. For your other Medicare drugs, check what your Part D plan covers before paying cash.
The deepest cuts are in GLP-1 weight-loss and diabetes medications, where list prices ran $1,000–$1,350 per month before TrumpRx. The oral Wegovy pill dropped from $1,349 to $149 — an 89% reduction. The injectable Ozempic and Wegovy pens start at $199/month for the initial two doses. Fertility drugs also saw dramatic cuts: Cetrotide (used in IVF) dropped 93%, from $316 to $22.50 per cycle; Gonal-F fell 83% from $966 to $168. For diabetes drugs, Januvia fell to $100 from $330; Jardiance came down 66% to $197 under Medicare negotiation pricing. The more complex the drug and the higher the original list price, the larger the TrumpRx discount tends to be.
This depends on your specific situation — and there’s a hidden cost that most people miss. You can technically use TrumpRx if you have private employer-sponsored insurance, but doing so means paying fully out of pocket, forfeiting insurance reimbursement rights, and — critically — the purchase does not count toward your deductible or annual out-of-pocket maximum. If you have a $3,000 deductible and spend $2,400 on TrumpRx prescriptions, you’re still at $0 toward your deductible for the year. For routine maintenance drugs where your insurance copay is already low, stick with insurance. For expensive specialty drugs that your plan doesn’t cover, TrumpRx can be a genuine lifesaver. Run the math both ways before deciding.
Yes — significantly. The platform launched February 5, 2026 with 43 brand-name drugs from five manufacturers. In May 2026, over 600 generic medications were added through integrations with Amazon Pharmacy, Cost Plus Drugs, and GoodRx. In June 2026, another 160 brand-name drugs were added. The platform now lists over 800 medications across two sections: “Presidential Deals” (the MFN brand-name pricing) and “Standard Prices” (the generic pricing through retail partners). If you checked in early 2026 and didn’t find your drug, it’s worth searching again. One honest caveat: despite the 800+ headline figure, brand-name MFN deals still cover a limited share of what the participating manufacturers actually sell — coverage within a given drug category can be uneven.
For GLP-1 drugs specifically — yes, in most cases TrumpRx cash prices are currently among the lowest available for self-pay patients. For other categories, it varies. Some TrumpRx drugs are priced identically to GoodRx or Cost Plus because those partners now power parts of the TrumpRx platform. The arthritis drug Humira appears on TrumpRx at $950 per dose, which sounds dramatic until you note that two biosimilar equivalents are also listed for $207.60 — a better deal hiding on the same platform. The essential habit: always compare TrumpRx prices against GoodRx, Cost Plus Drugs, and Mark Cuban’s Cost Plus specifically for your medication and dose before filling. Prices for the same drug can differ meaningfully even within a single platform by dosage strength.
No enrollment, no account, and no income documentation is required. The basic process: visit TrumpRx.gov, search your medication, see the listed price, print or screenshot a coupon or follow the link to the manufacturer’s direct purchase portal, then fill the prescription at a participating pharmacy. You do need a valid prescription from a licensed U.S. healthcare provider — the platform doesn’t bypass that requirement. The only eligibility gate is insurance status: you must not be enrolled in Medicare, Medicaid, TRICARE, VA benefits, or other government-funded programs when filling through TrumpRx’s cash-pay discounts. There is no income requirement for the standard program.
These are separate programs, though they operate toward the same goal of lower drug costs, and both delivered real price drops in 2026. The Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program produced the first 10 negotiated drugs, which took effect January 1, 2026 — including Eliquis (blood clots, down 56% to $231), Jardiance (diabetes, down 66% to $197), Farxiga (diabetes/heart failure, down 68% to $178.50), and Enbrel (arthritis, down 67% to $2,355). These IRA negotiated prices apply to Medicare Part D enrollees automatically — not through TrumpRx.gov — and they represent real savings for Medicare patients even though TrumpRx’s cash-pay discounts don’t apply to them. The two programs overlap in intent but serve different populations.
Prices shown reflect TrumpRx cash-pay MFN pricing and IRA Medicare-negotiated pricing as of mid-2026. All prices are for a standard one-month supply unless noted. Confirm current prices at TrumpRx.gov before filling — manufacturer deals can update.
| Drug (Brand) | Condition | Old List Price | New Price | Savings | Program |
|---|---|---|---|---|---|
| Wegovy pill (oral) | Obesity / Weight Loss | $1,349/mo | $149/mo | 89% off | TrumpRx cash |
| Wegovy pen (inject.) | Obesity / Weight Loss | $1,349/mo | $199–$349/mo | 74–85% off | TrumpRx cash |
| Ozempic pen | Type 2 Diabetes | $1,028/mo | $199–$349/mo | 66–81% off | TrumpRx cash |
| Zepbound vial | Obesity / Weight Loss | $1,087/mo | $299/mo | ~72% off | TrumpRx cash |
| Mounjaro | Type 2 Diabetes | $1,050+/mo | ~$350/mo | ~67% off | TrumpRx MFN |
| Januvia | Type 2 Diabetes | $330/mo | $100/mo | 70% off | TrumpRx MFN |
| Jardiance | Diabetes / Heart Failure | $573/mo | $197/mo | 66% off | IRA Medicare |
| Farxiga | Diabetes / Heart / Kidney | $556/mo | $178.50/mo | 68% off | IRA Medicare + TrumpRx |
| Trulicity | Type 2 Diabetes | $700+/mo | $389/mo | ~44% off | TrumpRx MFN |
| Jentadueto | Type 2 Diabetes | $525/mo | $55/mo | 90% off | TrumpRx MFN |
| Eliquis | Blood Clots / Stroke | $521/mo | $231/mo | 56% off | IRA Medicare |
| Xarelto | Blood Clots / Stroke | $517/mo | $197/mo | 62% off | IRA Medicare |
| Entresto | Chronic Heart Failure | $628/mo | $295/mo | 53% off | IRA Medicare |
| Humira (brand) | Arthritis / Inflammation | ~$7,000/dose | $950/dose | 86% off | TrumpRx MFN |
| Humira biosimilars | Arthritis / Inflammation | N/A | From $207.60/dose | Best value | TrumpRx listed |
| Enbrel | Rheumatoid Arthritis | $7,106/mo | $2,355/mo | 67% off | IRA Medicare |
| Xeljanz | Rheumatoid Arthritis | $2,277/mo | $1,518/mo | 33% off | TrumpRx MFN |
| Stelara | Psoriasis / Crohn’s | $13,836/mo | $4,695/mo | 66% off | IRA Medicare |
| Imbruvica | Blood Cancers | $13,900+/mo | ~$8,600/mo | 38% off | IRA Medicare |
| Repatha | High Cholesterol | $573/mo | $239/mo | 58% off | TrumpRx (Amgen deal) |
| Emgality | Migraines | $700+/mo | $299/mo | ~57% off | TrumpRx MFN |
| Gonal-F | Fertility (IVF) | $966/cycle | $168/cycle | 83% off | TrumpRx (EMD Serono) |
| Cetrotide | Fertility (IVF) | $316/cycle | $22.50/cycle | 93% off | TrumpRx (EMD Serono) |
| Ovidrel | Fertility (IVF) | $251/cycle | $84/cycle | 67% off | TrumpRx (EMD Serono) |
| Sanofi Insulin products | Diabetes (insulin) | Varies | From $35/mo | Varies | TrumpRx MFN |
TrumpRx prices change as new manufacturer agreements are signed and dosage-specific terms are finalized. The prices above represent mid-2026 data from the White House, CMS, and manufacturer announcements. “Starting at” prices on TrumpRx.gov reflect the lowest available dose — higher doses cost more. Always verify your specific drug and dosage at TrumpRx.gov before filling. Prices for GLP-1 injectable pens start at $199/month for the two lowest doses, then rise to $349/month after that. The $149 Wegovy price applies only to the oral pill formulation.
These are the drugs generating the most questions — and the most confusion. The prices look dramatically different depending on dose, formulation, and whether you’re paying through TrumpRx, Medicare, a telehealth service, or your pharmacy insurance. Here is what the numbers actually mean.
Wegovy is the injectable and oral form of semaglutide approved for chronic weight management. TrumpRx lists the oral Wegovy pill at $149 per month — an 89% reduction from the $1,349 list price, the deepest single discount currently on the platform. The injectable Wegovy pen starts at $199 per month for the two introductory doses (0.25 mg and 0.5 mg), then moves to $349 per month for higher maintenance doses. The introductory $199 pricing runs through December 31, 2026 for new self-pay patients. Medicare patients with qualifying obesity-related conditions gained coverage with a $50 maximum monthly copay starting mid-2026, administered through Part D plans — not through TrumpRx.gov. You need a valid prescription. TrumpRx connects you to the Novo Nordisk direct purchase portal where the discount applies.
Ozempic contains the same active ingredient as Wegovy (semaglutide) but is FDA-approved for type 2 diabetes management rather than obesity. The TrumpRx pricing structure is identical to Wegovy’s injectable pen: $199 per month for the first two fills (the 0.25 mg and 0.5 mg starting doses), then $349 per month for the higher doses typically used for ongoing diabetes management. Original list price was $1,028. This represents a 66–81% reduction depending on dose. The offer is for self-pay U.S. residents with a valid prescription who are not enrolled in Medicare, Medicaid, or other government programs. Medicare patients with diabetes already covered Ozempic before TrumpRx at negotiated Medicare rates — check your Part D plan’s specific copay before using TrumpRx instead.
Zepbound is Eli Lilly’s tirzepatide medication approved for obesity and weight management. TrumpRx lists the Zepbound vial at $299 per month, down from $1,087 — a roughly 72% reduction. Higher dose pens can still run $1,087 on TrumpRx, so always check the specific dose and formulation before assuming the lowest price applies to your prescription. Medicare patients gained access to Zepbound at a $50 maximum monthly copay starting mid-2026 under the Eli Lilly MFN agreement, administered separately from TrumpRx through Medicare Part D plans and Medicare Advantage plans that cover GLP-1s. The cash price is projected to trend down to $245 per month for non-starting doses under the terms of the MFN deal over the next two years.
TrumpRx launched with five manufacturers and has expanded. Here is every category of medication currently represented on the platform, with key drugs in each and what to expect price-wise.
This is the largest and most price-impacted category on TrumpRx. Includes GLP-1 injectables (Ozempic, Mounjaro, Trulicity), oral diabetes drugs (Januvia, Jardiance, Farxiga, Jentadueto, Xigduo XR), and Sanofi’s insulin products starting at $35 per monthly supply. The IRA also delivered negotiated Medicare pricing on Jardiance (–66%) and Farxiga (–68%), effective January 1, 2026. If you take a diabetes drug and are not on government insurance, TrumpRx should be your first stop before your next refill. The combination of TrumpRx cash-pay and MFN pricing has made these drugs genuinely affordable for uninsured and underinsured patients for the first time.
Four major cardiovascular drugs are now significantly cheaper through the IRA Medicare Drug Negotiation Program — Eliquis (blood clots, –56%), Xarelto (blood clots/stroke, –62%), Entresto (heart failure, –53%), and Farxiga (heart failure/CKD, –68%). These prices took effect January 1, 2026 for Medicare Part D enrollees. Repatha (high cholesterol, from Amgen) is discounted on TrumpRx from $573 to $239 for cash-pay patients. For Medicare patients, these drugs are now substantially cheaper through your Part D plan — you do not need to use TrumpRx and may not qualify for TrumpRx pricing. Ask your pharmacist to confirm you’re receiving the IRA negotiated rate at the point of sale.
This category includes some of the most expensive drugs in American medicine. Humira (adalimumab) appears on TrumpRx at $950 per dose, down from a list price near $7,000 — a large headline number, but the more important fact is that Humira biosimilars (Abrilada, Amjevita) are listed on TrumpRx for as little as $207.60 per dose. If your doctor has you on brand Humira, it’s worth asking whether a biosimilar would work for your condition. Enbrel dropped 67% for Medicare patients via IRA negotiation to $2,355/month — still expensive but significantly lower. Xeljanz’s TrumpRx price of $1,518/month after a 33% discount is a smaller relative reduction and still puts it out of reach for many without insurance. Stelara (psoriasis/Crohn’s) dropped 66% to $4,695 under IRA Medicare pricing.
Fertility drugs are among the most dramatically discounted items on TrumpRx and represent a genuinely meaningful development for patients who pay out of pocket for IVF. Gonal-F, Cetrotide, and Ovidrel from EMD Serono are available through Cigna’s Evernorth pharmacies, Freedom Fertility, and VFP Pharmacy Group via the TrumpRx platform. The savings are real: Cetrotide dropped 93%, from $316 to $22.50 per IVF cycle; Gonal-F fell 83% from $966 to $168. CMS estimates patients could save $2,200 per IVF cycle using all three medications at TrumpRx prices. Women’s health products from Pfizer include hormone therapies (Premarin, Prempro), menopausal treatments (Estring, Duavee), and Diflucan (antifungal). Fertility drug TrumpRx discounts apply to self-pay patients only — most fertility treatments are not covered by government programs, making this the most accessible category on the platform.
Emgality (galcanezumab, for migraines) dropped to approximately $299 per month on TrumpRx under the Eli Lilly MFN deal. Imbruvica (ibrutinib, for blood cancers including CLL and Waldenström’s macroglobulinemia) dropped 38% to approximately $8,600 per month under IRA Medicare negotiation — still expensive but representing significant savings on a drug that costs over $13,900 at list. AstraZeneca’s Farxiga, used for heart failure and chronic kidney disease in addition to diabetes, also covers these conditions at the $178.50 MFN/IRA price. Eye drops for glaucoma (Alphagan P) and other specialty medications appear on the expanded platform. For cancer patients specifically: the IRA negotiated prices apply to Medicare Part D — always verify with your oncologist and pharmacist that your Part D plan is billing at the 2026 negotiated rate, not the prior list price.
The process is simpler than most people expect. There’s no enrollment form, no income test, and no account to create. What you do need: a prescription and cash or a debit/credit card.
Go to TrumpRx.gov and type your medication name in the search field. If your drug is listed, the platform shows the discounted cash price alongside the original list price. Be specific about the dosage — prices vary significantly by strength. The platform has two sections: “Presidential Deals” (the brand-name MFN negotiated prices from participating manufacturers) and “Standard Prices” (generic pricing sourced through Amazon Pharmacy, Cost Plus Drugs, and GoodRx). Both can show significant savings; the sections are distinct and listed separately on the site.
Depending on the drug and manufacturer, TrumpRx does one of two things: it generates a downloadable coupon you take to a participating pharmacy, or it redirects you to the manufacturer’s own direct-to-consumer portal where you complete the purchase. Pfizer’s 30+ drugs on the platform use GoodRx as the integrated pricing engine — clicking through to Pfizer’s drugs generates a GoodRx coupon. Novo Nordisk and Eli Lilly GLP-1 drugs link to those companies’ own patient portals. Fertility drugs route to Cigna’s Evernorth, CVS Health, or VFP Pharmacy Group partners. Screenshot the price page before clicking through — prices can vary slightly between the TrumpRx listing and the manufacturer portal.
Present the coupon at the pharmacy counter and tell them you are paying cash, not using insurance. This is important: the pharmacist must process your prescription as a cash transaction using the TrumpRx coupon — not run it through your insurance first. If your pharmacy tries to run it through insurance, stop them. The TrumpRx discount is incompatible with insurance billing. For manufacturer portal purchases (Novo Nordisk, Eli Lilly), the medication may be shipped directly to your home or directed to a specific dispensing pharmacy partner. You do not need to show proof of income, insurance status, or citizenship — only a valid U.S. prescription.
Before filling via TrumpRx, run this comparison: call your pharmacy and ask what your insurance copay would be for the same drug. If the copay is lower than TrumpRx, use your insurance — and that purchase counts toward your deductible. If TrumpRx is lower and you have a high deductible you are unlikely to reach this year, TrumpRx cash is probably the right call. If you have a high deductible that you expect to meet because of other medical costs coming up, using TrumpRx could save money on the drug but cost you more overall by leaving your deductible unmade. This tradeoff is the most important financial calculation most TrumpRx users don’t know to make.
If you have no insurance or private employer insurance only: go to TrumpRx.gov with your prescription and access the Novo Nordisk direct portal. The oral Wegovy pill is the cheapest option at $149 per month. Injectable Wegovy and Ozempic pens start at $199 per month for the two introductory doses, then move to $349 per month. The injectable Zepbound vial is $299 per month. These are the lowest available prices on FDA-approved brand-name GLP-1 medications in the U.S. for self-pay patients as of September 2026. You must have a valid prescription — if you don’t have a doctor, telehealth providers partner with TrumpRx to provide both the prescription and the medication at TrumpRx prices in one visit. If you have Medicare: you don’t use TrumpRx — your Part D plan now covers qualifying GLP-1s with a maximum $50 monthly copay. Ask your doctor and your Part D plan directly.
Yes — significantly, and you may not have been told. Eliquis and Xarelto are among the first 10 drugs whose prices were negotiated under the Inflation Reduction Act, and the new rates took effect January 1, 2026 in Medicare Part D. Eliquis dropped 56% to $231 per month; Xarelto dropped 62% to $197 per month. These savings happen automatically through your Part D plan at the pharmacy — you don’t need to do anything to access them. But you do need to check that your pharmacy is billing at the 2026 negotiated rate. Call your Part D plan and ask: “What is my 2026 copay for Eliquis/Xarelto at the negotiated Medicare price?” If your pharmacist is still billing the old list price, that is an error. TrumpRx is not the right channel for Medicare patients for these drugs.
Fertility drugs are one of the most compelling categories on TrumpRx and the one where the discounts matter most for patients who universally pay out of pocket. The three key IVF medications — Gonal-F, Cetrotide, and Ovidrel — are available at 67–93% off their list prices through TrumpRx, filled through Cigna’s Evernorth pharmacies, CVS Health, or VFP Pharmacy Group. CMS estimates the three together save $2,200 per IVF cycle. Most fertility patients do not have government insurance covering fertility treatments, which means TrumpRx eligibility restrictions don’t typically apply. The important steps: (1) check that your fertility clinic is aware of TrumpRx pricing and can write the prescription to the right dispensing partner, (2) confirm you are not enrolled in any government drug benefit program, (3) ask whether the deeper Compassionate Care program (EMD Serono) applies if your household income is low — it offers up to 50% additional savings beyond TrumpRx.
The Humira situation on TrumpRx illustrates something worth understanding about the platform broadly. The brand Humira lists at $950 per dose on TrumpRx — an 86% reduction from list. But Humira’s patent expired in 2023, and two biosimilar versions (Abrilada, Amjevita) are also on TrumpRx at $207.60 per dose. These biosimilars are FDA-approved to be interchangeable with Humira for most indications. The White House press coverage highlighted the 86% brand discount; the bigger practical opportunity is the biosimilar option. Talk to your rheumatologist — for most patients with rheumatoid arthritis, psoriatic arthritis, or Crohn’s disease, a biosimilar is clinically equivalent and significantly cheaper. If you are on Medicare, Enbrel dropped 67% to $2,355/month via IRA negotiation — ask your Part D plan about your 2026 copay.
TrumpRx cash-pay discounts are not available to Medicaid enrollees. However, separate MFN pricing was negotiated to apply to Medicaid programs directly — meaning the state Medicaid program pays less for drugs like Ozempic, Wegovy, and others under the manufacturer deals, and Medicaid enrollees typically pay nothing out of pocket anyway. The bigger issue for Medicaid patients is access — not price. If a drug you need is covered by your state’s Medicaid formulary, your copay is already $0–$4 in most states. If a drug you need isn’t covered, contact your state’s Medicaid office to ask whether a prior authorization exception can be filed for medical necessity. The drug prices shown on TrumpRx do not apply to your program.
TrumpRx is not the only way to access discounted medications. If your drug isn’t listed, three parallel paths are worth exploring immediately. First, Mark Cuban’s Cost Plus Drugs (costplusdrugs.com) — which now integrates with TrumpRx for generics but also maintains its own separate lower-cost catalog, often with deeper discounts on generic drugs than anywhere else in the U.S. Second, GoodRx.com — type your drug and ZIP code to see the lowest available coupon price at pharmacies within a mile. Third, the manufacturer’s own patient assistance program: virtually every major drug maker runs a program for patients who can’t afford their medication. Call the manufacturer directly and ask for their Patient Assistance Program or Affordability Program. For Medicare patients, the Extra Help / Low Income Subsidy (LIS) program covers Part D premiums, deductibles, and copays for qualifying lower-income beneficiaries — call 1-800-MEDICARE to find out if you qualify.
This guide is for informational purposes only and does not constitute medical or financial advice. Drug prices change frequently as new manufacturer agreements are signed. Always verify current pricing directly at TrumpRx.gov before filling a prescription. TrumpRx.gov cash-pay discounts do not apply to Medicare, Medicaid, TRICARE, VA, or other government-funded health program enrollees. IRA Medicare-negotiated prices apply through Medicare Part D — verify with your plan. This content is entirely original. Key sources: White House Fact Sheets, HHS.gov, Congress.gov CRS, Experian, NerdWallet, CMS.gov.